- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04343664
Mental Health Assessment Among Community Member During the Covid-19 Pandemic in Indonesia (New)
February 5, 2021 updated by: Tjhin Wiguna
The Covid-19 pandemic in Indonesia makes several changes in daily living.
The Indonesian government suggests that everyone should stay at home by implements the work from home and school from home.
Therefore, the issues related with Covid-19 are also worrying such as death because of the infection, virus transmission, doing everything from home such as Friday praying for Moslem, Sunday service at home, etc.
People is anxious whenever meeting people because they are not really understand whether people is infected or not.
Therefore, this study tries to identify the impact of Covid-19 pandemic in Indonesia towards mental well-being of the community.
Study Overview
Status
Not yet recruiting
Detailed Description
The Covid-19 pandemic in Indonesia makes several changes in daily living.
The Indonesian government suggests that everyone should stay at home by implements the work from home and school from home.
Therefore, the issues related with Covid-19 are also worrying such as death because of the infection, virus transmission, doing everything from home such as Friday praying for Moslem, Sunday service at home, etc.
People is anxious whenever meeting people because they are not really understand whether people is infected or not.
Therefore, this study tries to identify the impact of Covid-19 pandemic in Indonesia towards mental well-being of the community.
The aims of this study are trying to collect and identify the most important aspect of mental health that affected by the Covid-19 pandemic in Indonesia, and using this data we are trying to propose the exact mental health promotion and prevention program for the community.
The study design is cross sectional.
We develop the questionnaire that suitable for our study, consists of demographic data, life experience data.
In addition, for assessing mental health problems, the study uses PHQ-9, SRQ-20, GAD-7, SDQ for children 4 - 10 years old and 11 - 17 years old.
The study is done by online survey.
The data analysis is done by SPSS for mac version 21.
Study Type
Observational
Enrollment (Anticipated)
10000
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Tjhin Wiguna, PhD
- Phone Number: +628129005599
- Email: twiga00@yahoo.com
Study Contact Backup
- Name: Belinda J Murtani, dr.
- Phone Number: +62817198097
- Email: belindamurtani@yahoo.com
Study Locations
-
-
DKI Jakarta
-
Jakarta Pusat, DKI Jakarta, Indonesia, 10430
- Dr. Cipto Mangunkusumo General Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
4 years and older (Child, Adult, Older Adult)
Accepts Healthy Volunteers
N/A
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
All children, parents and community members
Description
Inclusion Criteria:
- Willing to participate on this study by signing the informed consent
Exclusion Criteria:
- No
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Ecologic or Community
- Time Perspectives: Cross-Sectional
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Depression
Time Frame: up to 5 minutes
|
The depression symptoms assessed by Patient Health Queationnaire-9 Scale.
The range is 0 -27, the highest score means the highest depresive
|
up to 5 minutes
|
Anxiety symptoms
Time Frame: up to 5 minutes
|
The anxiety symptoms assessed by Generalized Anxiety Disorder -7 Scale.
It is consists of 7 item with ranged score 0 -21.
The highest score means the highest anxiety
|
up to 5 minutes
|
Stress related problems
Time Frame: up to 7 minutes
|
The stress related problems assessed by Self Reporting Questionnaire-20 Scale.
The range is 0 -20, the highest score means the highest mental health problems
|
up to 7 minutes
|
Behavior and emotional problem among children and adolescents
Time Frame: up to 5 minutes
|
Behavior and emotional problem among children and adolescents assessed by Strength and Difficulties Questionnaire.
SDQ consists of 25 statements, the score is ranged from 0 - 60.
The highest score means the highest problems
|
up to 5 minutes
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Tjhin Wiguna, PhD, Dr Cipto Mangunkusumo General Hospital
- Principal Investigator: Tjhin Wiguna, PhD, Fakultas Kedokteran Univeristas Indonesia
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Anticipated)
February 1, 2021
Primary Completion (Anticipated)
November 1, 2021
Study Completion (Anticipated)
December 31, 2021
Study Registration Dates
First Submitted
April 9, 2020
First Submitted That Met QC Criteria
April 9, 2020
First Posted (Actual)
April 13, 2020
Study Record Updates
Last Update Posted (Actual)
February 9, 2021
Last Update Submitted That Met QC Criteria
February 5, 2021
Last Verified
February 1, 2021
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- MH-Covid19
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
IPD Plan Description
Undecided yet
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Depression
-
ProgenaBiomeRecruitingDepression | Depression, Postpartum | Depression, Anxiety | Depression Moderate | Depression Severe | Clinical Depression | Depression in Remission | Depression, Endogenous | Depression ChronicUnited States
-
Washington University School of MedicineCompletedTreatment Resistant Depression | Late Life Depression | Geriatric Depression | Refractory Depression | Therapy-Resistant DepressionUnited States, Canada
-
Kintsugi Mindful Wellness, Inc.Sonar Strategies; Vituity PsychiatryRecruitingDepression | Depression Moderate | Depression Severe | Depression MildUnited States
-
University of California, San FranciscoRecruitingDepression Moderate | Depression Mild | Depression, TeenUnited States
-
University GhentUniversiteit Antwerpen; Janssen-Cilag Ltd.RecruitingDepression Moderate | Depression Severe | Depression MildBelgium
-
Baylor College of MedicineUniversity of TexasRecruitingDepression | Depression Moderate | Depression Severe | Suicide and Self-harm | Depression in Adolescence | Depression MildUnited States
-
University of Cape TownNational Institute of Mental Health (NIMH)CompletedPostpartum Depression | Clinical Depression | Moderate DepressionSouth Africa
-
Northern Illinois UniversityUniversity Autonoma de Santo DomingoTerminatedDepression Moderate | Depression MildUnited States, Dominican Republic
-
Lawson Health Research InstituteTerminated
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; National Institute of Mental...CompletedMajor Depressive Disorder | Treatment Resistant Depression | Treatment-Refractory Depression | Late Life Depression | Geriatric DepressionUnited States, Canada